Table 8.

Left ventricular myocardial oxidative stress

	SHR (n = 8)	SHR-APO (n = 8)	SHR-DM (n = 8)	SHR-DM-APO (n = 8)
AGEs	2.47 (2.35–4.16)	2.54 (1.90–3.86)	2.61 (1.83–4.16)	2.68 (2.09–4.97)
DHE	39.1 (38.2–39.7)	39.9 (39.0–40.2)	39.5 (37.4–40.6)	39.4 (38.2–40.2)
EOH	39.6 (31.9–47.6)	38.4 (31.7–40.2)	34.5 (22.4–38.0)	33.2 (29.1–40.1)
E	112 (86.6–165)	97.5 (85.9–222)	119 (112–163)	129 (106–164)

Data are expressed as mean ± standard deviation or median and 25th and 75th percentile

SHR spontaneously hypertensive rats; SHR-APO SHR treated with apocynin; SHR-DM diabetic SHR; SHR-DM-APO diabetic SHR treated with apocynin; AGEs advanced glycation end-products (%); DHE dihydroethidium (µM); EOH 2-hydroxyethidium (µM); E ethidium (µM)

Two-factor ANOVA; p > 0.05